19-066
Showing 1 - 25 of >10,000
Diffuse Large B Cell Lymphoma Trial in Tianjin (C-CAR066)
Unknown status
- Diffuse Large B Cell Lymphoma
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Mar 18, 2020
COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)
Active, not recruiting
- COVID-19
- AZD7442
- +2 more
-
Tucson, Arizona
- +123 more
Mar 24, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
B Cell Lymphoma Trial in Shanghai (CD20-directed CAR-T cells)
Unknown status
- B Cell Lymphoma
- CD20-directed CAR-T cells
-
Shanghai, ChinaShanghai Tongji Hospital, Tongji University School of Medicine
Jul 25, 2019
Rheumatoid Arthritis,Osteoarthritis Trial (MK0663, etoricoxib, Comparator: Diclofenac sodium)
Completed
- Rheumatoid Arthritis,Osteoarthritis
- MK0663, etoricoxib
- Comparator: Diclofenac sodium
- (no location specified)
Feb 7, 2022
Stereotype-threat, COVID-19 Trial in Ankara (stereotype threat manipulation)
Completed
- Stereotype-threat
- COVID-19
- stereotype threat manipulation
-
Ankara, TurkeyHacettepe University Hospital
Jan 2, 2023
Cancer Trial in New York (in-person geriatric co-management, automated geriatric co-management)
Recruiting
- Cancer
- in-person geriatric co-management
- automated geriatric co-management
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 15, 2021
Healthy Subjects, COVID-19 Pneumonia, Irritable Bowel Syndrome Trial in Hualien City (Jing Si Herbal Tea Liquid Packet, Jing Si
Recruiting
- Healthy Subjects
- +3 more
- Jing Si Herbal Tea Liquid Packet
- Jing Si Herbal Tea Liquid Packet Placebo
-
Hualien City, TaiwanHualien Tzu Chi Hospital
Jan 2, 2023
COVID-19, SARS-CoV-2 Trial in Worldwide (AZD5156, Placebo, AZD7442 (EVUSHELD™))
Recruiting
- COVID-19, SARS-CoV-2
- AZD5156
- +2 more
-
Buenos Aires, Argentina
- +20 more
Jan 12, 2023
Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer Trial in Boston (MRI)
Recruiting
- Breast Cancer
- +5 more
- MRI
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 9, 2022
COVID-19 Pandemic Trial in Yogyakarta (Coping and Resilience Intervention for Adolescents, Printing materials of Coping and
Enrolling by invitation
- COVID-19 Pandemic
- Coping and Resilience Intervention for Adolescents
- Printing materials of Coping and Resilience Intervention for Adolescents
-
Yogyakarta, IndonesiaOkki Dhona Laksmita
Apr 25, 2023
Moral Injury, Distress, Emotional Trial in Toronto (Educational moral injury video)
Completed
- Moral Injury
- Distress, Emotional
- Educational moral injury video
-
Toronto, Ontario, CanadaSt. Michael's Hospital
Oct 5, 2021
Patient With Anterior Myocardial Infarction Trial in Sohag (-group of patients(75 patients) will receive low dose rivaroxaban
Not yet recruiting
- Patient With Anterior Myocardial Infarction
- -group of patients(75 patients) will receive low dose rivaroxaban myocardial infarction plus (acetylsalicylic acid 75 mg and clopidogrel 75 mg
- (acetylsalicylic acid 75 mg once daily orally and clopidogrel 75 mg once daily orally only)
-
Sohag, EgyptSohag University Hospital
Feb 16, 2023
Severe Pneumonia Trial in São Paulo, Milan, Varese (Reparixin, Standard of care)
Intraoperative Monitoring Trial in Cluj-Napoca (Intra-operative analgesia guided by SPI)
Recruiting
- Intraoperative Monitoring
- Intra-operative analgesia guided by SPI
-
Cluj-Napoca, RomaniaFirst Surgical Clinic, County Hospital
May 22, 2023
Education, Nursing Trial in Pamplona (Health coaching)
Completed
- Education
- Nursing
- Health coaching
-
Pamplona, Navarra, SpainUCEC
Jan 27, 2023
Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)
Completed
- Ulcerative Colitis (UC)
- Crohn's Disease
- Risankizumab
- Cytochrome P450 (CYP) Substrates
-
Coronado, California
- +5 more
Oct 20, 2022
Obese Patients With Non-alcoholic Steatohepatitis (NASH) Trial in Worldwide (LIK066, Placebo)
Completed
- Obese Patients With Non-alcoholic Steatohepatitis (NASH)
- LIK066
- Placebo
-
Baton Rouge, Louisiana
- +14 more
Oct 7, 2021
Coronavirus Trial in Cambridge (Messaging)
Completed
- Coronavirus
- Messaging
-
Cambridge, MassachusettsJPAL North America
Jul 24, 2021